Scholarlink

Background <p><i>Pseudomonas aeruginosa</i> is a multidrug-resistant pathogenic bacterium that poses a substantial threat to global public health because of its resistance to antibiotics, and especially to last-resort colistin. The aim of this study is to perform a comparative analysis between the antibiotic-sensitive isolate A and the resistant isolate C (8&#xa0;µg/mL for isolate A and 128&#xa0;µg/mL for isolate C), with the intent of elucidating the discrete molecular mechanisms underpinning resistance. This investigation seeks to distinguish between pathways inherently expressed in the absence of antibiotic exposure (acquired resistance) and those activated in response to antibiotic challenge (induced resistance), thereby providing deeper insights into the multifaceted nature of antimicrobial resistance in <i>P. aeruginosa.</i></p> Results <p>Proteomic analysis, performed under basal conditions and after exposure to increasing doses of colistin, revealed that, although both isolates have intrinsic resistance to several antimicrobials, the mechanisms underlying colistin resistance diverge significantly. While isolate A showed a stable proteomic response, characterized by the overexpression of proteins related to membrane remodeling and efflux systems, isolate C demonstrated a more dynamic response, evidenced by metabolic adaptations and oxidative stress mitigation mechanisms. These differences suggest that each isolate employs specific strategies to cope with antimicrobial pressure, which has direct implications for the choice of alternative therapies and the development of optimized dosing regimens.</p> Conclusions <p>The findings have direct implications for the choice of alternative therapies and the development of optimized dosing regimen. In summary, the results reinforce the complexity of resistance mechanisms in <i>P. aeruginosa</i> and highlight the importance of personalized therapeutic approaches for the management of infections caused by multidrug-resistant isolates.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Distinct proteomic profiles of clinical isolates show diversity of Pseudomonas aeruginosa colistin-resistance

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月10日

查看全文
  • Telma de Sousa,
  • Thierry Sayd,
  • Didier Viala,
  • Christophe Chambon,
  • Manuela Caniça,
  • Miguel J. N. Ramos,
  • Patrícia Poeta,
  • Michel Hébraud,
  • Gilberto Igrejas

摘要

Background

Pseudomonas aeruginosa is a multidrug-resistant pathogenic bacterium that poses a substantial threat to global public health because of its resistance to antibiotics, and especially to last-resort colistin. The aim of this study is to perform a comparative analysis between the antibiotic-sensitive isolate A and the resistant isolate C (8 µg/mL for isolate A and 128 µg/mL for isolate C), with the intent of elucidating the discrete molecular mechanisms underpinning resistance. This investigation seeks to distinguish between pathways inherently expressed in the absence of antibiotic exposure (acquired resistance) and those activated in response to antibiotic challenge (induced resistance), thereby providing deeper insights into the multifaceted nature of antimicrobial resistance in P. aeruginosa.

Results

Proteomic analysis, performed under basal conditions and after exposure to increasing doses of colistin, revealed that, although both isolates have intrinsic resistance to several antimicrobials, the mechanisms underlying colistin resistance diverge significantly. While isolate A showed a stable proteomic response, characterized by the overexpression of proteins related to membrane remodeling and efflux systems, isolate C demonstrated a more dynamic response, evidenced by metabolic adaptations and oxidative stress mitigation mechanisms. These differences suggest that each isolate employs specific strategies to cope with antimicrobial pressure, which has direct implications for the choice of alternative therapies and the development of optimized dosing regimens.

Conclusions

The findings have direct implications for the choice of alternative therapies and the development of optimized dosing regimen. In summary, the results reinforce the complexity of resistance mechanisms in P. aeruginosa and highlight the importance of personalized therapeutic approaches for the management of infections caused by multidrug-resistant isolates.